DIETHYL 2-(((4-(METHOXYCARBONYL)THIOPHEN-3-YL)AMINO)METHYLENE)MALONATE, 90.0%, 100mg

5-Bromopentan-1-amine hydrobromide, 95%, 5g

4-Fluoro-5-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 98%, 1g

(2-Chlorothiazol-5-yl)methylamine hydrochloride, 95.0%, 1g

N,N-Bis(3-chlorobenzyl)amine>98.0%(GC)25g

quinoline-8-sulfonamide, 95+%, 1g

GC capillary column ROTI®Cap-1, 30 m, 0.53 mm, 1.00 µm, 1 Piece(s)

2-(3-Ethoxy-4-(ethoxycarbonyl)phenyl)acetic acid, 95.0%, 100g

2-Aminoacetophenone hydrochloride, 98.0%, 100g

Benzyl (S)-3-((tert-butoxycarbonyl)amino)pyrrolidine-1-carboxylate, 98%, 5g

tert-Butyl (S)-1-(((R)-tert-butylsulfinyl)amino)-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate, 98.0%, 100mg

Hexahydro-pyrrolo[1,2-a]pyrazin-6-one, 95.0%, 1g

cis-3-Hexen-1-ol>97.0%(GC)25mL